Technical analysis of HUTCHMED (China) Limited (HCM): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
HUTCHMED (China) Limited is a biopharmaceutical firm dedicated to the discovery, advancement, and marketing of innovative targeted and immune-based treatments for various cancers and immune-related disorders. Its operations are divided into two main areas: Oncology/Immunology and a segment encompassing Other Ventures. The company's reach extends from Hong Kong globally.
Price Performance
| 1 month | -5.87% |
| 3 months | +19.68% |
| Year-to-date | -0.08% |
| 1 year | -9.45% |
| 3 years | -34.16% |
| 5 years | -54.72% |
| 10 years | +10.45% |
52-Week Range
| 52-week High | $16.33 |
| 52-week Low | $9.77 |
| Avg Volume (90d) | 63K |
Technical Indicators
| SMA 50 | $13.62 |
| SMA 200 | $13.24 |
| Beta | 0.45 |
| 30-day Volatility (annualised) | 40.3% |
| Price vs SMA 50 | -2.2% |
| Price vs SMA 200 | +0.6% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $13.33 | |
| 2026-01 | $15.00 | +12.5% |
| 2026-02 | $14.33 | -4.5% |
| 2026-03 | $14.96 | +4.4% |
| 2026-04 | $13.44 | -10.2% |
| 2026-05 | $11.45 | -14.8% |
| 2026-06 | $10.76 | -6.0% |
| 2026-07 | $11.13 | +3.4% |
| 2026-07 | $11.13 | +0.0% |
| 2026-08 | $12.12 | +8.9% |
| 2026-09 | $14.63 | +20.7% |
| 2026-10 | $13.32 | -9.0% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-03-04 | $0.21 | $329M |
| 2026-07-30 | $0.14 | $304M |
| 2026-07-02 | $-0.36 | $81M |
| 2026-03-05 | $2.50 | $291M |
| 2025-08-07 | $1.46 | $330M |
| 2025-07-02 | $-0.32 | $57M |
| 2025-03-19 | $0.04 | $319M |
Price
| Price | $14.37 (closing price, October 28, 2026) |
| Market Cap | $2.5B |
| Exchange | NASDAQ |
| Country | HK |
Valuation Ratios
| P/E Ratio | 139.51 |
| Price / Book | 1.87 |
| EV / EBITDA | -114.53 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.07 |
| Current Ratio | 5.64 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 3.50 |